Europe — EMA

Olmesartan Medoxomilo Zentiva

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo Zentiva, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to treat high blood pressure in adult patients. GNH USA supplies Olmesartan Medoxomilo Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomilo Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxil is an angiotensin II receptor blocker indicated for conditions affecting the cardiovascular system.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: helps slow the progression of kidney damage associated with diabetes.

What are the side effects of Olmesartan Medoxomil?

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea

Serious or Rare Side Effects: - Angio‑edema - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver enzyme elevations

What precautions apply to Olmesartan Medoxomil?

When prescribing Olmesartan medoxil, clinicians should consider several safety aspects.

- Monitor blood pressure: ensure adequate control without excessive lowering. - Assess renal function: adjust use in patients with impaired kidneys. - Check electrolytes: watch for potassium abnormalities. - Review concomitant medications: avoid drugs that increase potassium levels. - Pregnancy: contraindicated in the second and third trimesters. - Store at ambient: keep the tablets in the original packaging ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

What does Olmesartan Medoxomil interact with?

The safety ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →